Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mark Emig (NPI 1235111212)

Field	Value
Entity Type	Individual
Organization	Mark Emig
Address	4353 Dodge St
City	Omaha
State	NE
ZIP	68131
Taxonomy	Ophthalmology Physician
NPI Enumerated	November 16, 2005

Payer Source	Total Paid
Medicare	$2.2M
Medicaid	$0

Key Findings

This provider’s billed footprint is concentrated in Medicare: Total Medicare revenue is $2.2M while Total Medicaid revenue is none (no Medicaid billing on file), making MARK EMIG effectively a single‑payer (Medicare) billing profile rather than a dual‑payer practice. The NPI was enumerated (registered) on 2005-11-16 (~21 years ago), indicating an established clinical presence in Omaha over two decades.

The business mix is heavily retina‑focused based on the top revenue codes: J0178 (aflibercept) and J2777 (faricimab) are the two largest revenue drivers alongside the intravitreal procedure code 67028. J0178 shows 1.4K claims, $679 avg paid/claim, $976.4K revenue (45.0% of this provider's total Medicare revenue) and J2777 shows 23.3K claims, $29 avg paid/claim, $676.9K revenue (31.2% of this provider's total Medicare revenue), which together with 67028 supports a service‑line profile built around intravitreal anti‑VEGF and related retina injections.

Revenue concentration is high: the precomputed top‑3 Medicare codes account for 81.6% of this provider's total Medicare revenue, signaling material dependence on a small set of injection and procedure codes. That concentration means changes in anti‑VEGF utilization, reimbursement, or drug mix could produce outsized revenue impacts for this clinician.

Competitive standing on the primary injection codes is above average but not market‑dominant nationally: J0178 ranks #868 of 3204 providers nationally (73th percentile; typical, unremarkable volume for this code), J2777 ranks #431 of 2039 providers nationally (79th percentile; typical, unremarkable volume for this code), and 67028 ranks #844 of 4255 providers nationally (80th percentile; typical, unremarkable volume for this code). These percentiles indicate stronger‑than‑median utilization of retina injections relative to peers, consistent with a regionally meaningful retina practice rather than a top national outlier.

Service mix shows some divergence between procedure and evaluation patterns: office E/M code 99213 is relatively high in volume (1.1K claims, $58 avg paid/claim, $61.7K revenue, 2.8% of Medicare revenue) and is labeled an extreme outlier (ranks #5550 of 457151 providers nationally; 99th percentile), suggesting an unusually large number of lower‑level established patient visits compared with national peers. Diagnostic imaging is also elevated for retina work—92134 has 2.1K claims, $28 avg paid/claim, $58.2K revenue (2.7% of Medicare revenue) and is described as notably above typical national volume (ranks #968 of 26868; 96th percentile)—supporting the interpretation of a busy injection plus monitoring workflow.

Smaller revenue streams include unclassified drug and newer agent billing: J3490 shows 21 claims, $1780 avg paid/claim, $37.4K revenue (1.7% of Medicare revenue) and J2781 (pegcetacoplan) shows 255 claims, $120 avg paid/claim, $30.6K revenue (1.4% of Medicare revenue). Both appear as modest contributors relative to the dominant anti‑VEGF codes and have percentile placements characterized as typical or low in the national distributions, indicating limited diversification beyond the primary retina drug suite.

Operationally, the combination of long tenure (enumerated 2005-11-16 (~21 years ago)) and a heavily injection‑driven revenue mix suggests MARK EMIG operates an established ophthalmology/retina practice model focused on recurring intravitreal therapy and monitoring visits. For payers and analysts, the profile flags predictable, procedure‑and‑drug‑centric utilization with concentrated Medicare revenue and no Medicaid billing on file, which is important for contracting, utilization management, and forecasting efforts.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,440	$680	$976.4K
J2777	Injection, faricimab‑svoa, 0.1 mg	23,340	$30	$676.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,450	$80	$119K
J2778	Injection, ranibizumab, 0.1 mg	590	$180	$105.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,060	$60	$61.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,080	$30	$58.2K
J3490	Unclassified drugs	20	$1,780	$37.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	260	$120	$30.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	400	$80	$30K
J3590	Unclassified biologics	260	$70	$18.2K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Mark Emig — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	9	10	25,950	$30	$1.5M
J0178	7	20	880	$690	$722.7K
J2778	8	10	670	$180	$137.8K
67028	10	20	1,070	$80	$106.4K
J2781	4	10	340	$120	$47.8K
J9035	7	10	30	$50	$47.1K
J3590	10	10	430	$70	$29.7K
67042	12	10	30	$1,100	$29.6K
66821	63	80	80	$210	$23K
92014	62	270	170	$70	$20K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mark Emig, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Physicians Clinic Inc	NE	Family Medicine Physician	$0	$20.5M
Matthew Appenzeller	NE	Ophthalmology Physician	$2.5M	$0
David Ingvoldstad	NE	Ophthalmology Physician	$1.8M	$0
Montgomery County Memorial Hospital	IA	Critical Access Hospital	$0	$1.7M
Bliss O'bryhim	MO	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Edward Taylor	NE	Internal Medicine Physician	$658.9K	$0
Michael Feilmeier	NE	Ophthalmology Physician	$617.6K	$0
Patricia Terp	NE	Ophthalmology Physician	$529.1K	$0
Thomas Franco	NE	Physical Medicine & Rehabilitation Physician	$526.6K	$0
Jesse Himebaugh	NE	Ophthalmology Physician	$412.6K	$0

Nearby Providers

Other providers in the same ZIP code as Mark Emig, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Father Flanagan's Boys' Home	NE	Pediatrics Physician	$0	$23.1M
Father Flanagan's Boys' Home	NE	Children's Hospital	$0	$16.2M
Emergency Physician Associates Of Nebraska PC	NE	Emergency Medicine Physician	$0	$4.9M
Dialysis Clinic Inc.	NE	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$3.9M
Alegent Health Bergan Mercy Health System	NE	Psychiatry Physician	$0	$3.4M
Midwest Eye Surgery Center, LLC	NE	Ambulatory Surgical Clinic/Center	$1.8M	$0
Haysam Akkad	NE	Interventional Cardiology Physician	$817.6K	$0
Pamela Helem	NE	Mental Health Counselor	$0	$680.9K
Melissa Darling	NE	Dermatology Physician	$501.5K	$0
Santa Monica	NE	Community/Behavioral Health Agency	$0	$458.5K

Mark Emig — Billing Profile & Reimbursement Data

Sign up for Mark Emig — Billing Profile & Reimbursement Data policy alerts

Mark Emig — Billing Profile & Reimbursement Data

Sign up for Mark Emig — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References